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Abstract
The chromosomal passenger complex (CPC) comprises at least four protein components and
functions at various cellular localizations during different mitotic stages to ensure correct
chromosome segregation and completion of cytokinesis. Borealin, the most recently identified
member of the CPC, is an intrinsically unstructured protein of low solubility and stability. Recent
reports have demonstrated the formation binary or ternary CPC sub-complexes incorporating short
Borealin fragments in vitro. Using isothermal titration calorimetry, we show that full-length
Borealin, instead of a Borealin fragment possessing the complete Survivin and INCENP-
recognition sequence, is required for the composition of a Borealin-Survivin complex competent
to interact with INCENP. In addition, we show evidence that full-length Borealin, which forms
high-order oligomers in its isolated form, is a monomer in the Borealin-Survivin CPC sub-
complex.
INTRODUCTION
The CPC functions in various key mitotic events, including chromatin modification
(phosphorylation of histone H3), correction of kinetochore attachment errors, quality control
of the spindle assembly checkpoint, the assembly of a stable bipolar spindle, chromosome
segregation and completion of cytokinesis (1-4). During the progression of mitosis, the CPC
moves to a series of locations in the cell, activating substrates in a coordinated fashion.
Specifically, during prometaphase when chromosomes begin to bind to microtubules, the
CPC localizes at the centromeres, which are the regions of the chromosomes to which the
mitotic spindle fibers attach. At the onset of anaphase when chromosomes start to migrate to
opposite poles of the cell, the CPC relocates to the central spindle. A fraction of the CPC
then moves to the equatorial cortex just before cleavage furrow assembly and the ensuing
cytokinesis (1-4). Despite the intriguing localization patterns of the CPC at mitosis, it is
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currently largely a mystery what the localization-specific CPC targets are at various mitotic
stages, and the precise mechanistic basis of CPC function remains unclear.
There are four reported chromosomal passenger proteins within the CPC: the serine-
threonine kinase Aurora B, the catalytic core of the CPC whose function is regulated by
phosphorylation as well as by association with other CPC components (5-9); the inner
centromere protein INCENP, an activating and targeting subunit of the CPC (10-13);
Survivin, a protein that plays a clear role in cell mitosis (14, 15) and a plausible role in
apoptosis which is based principally on the sequence composition of Survivin that includes a
baculovirus inhibitor of apoptosis protein (IAP) repeat (BIR), and the observed over-
expression of Survivin in a variety of cancer cells (16-18); and Borealin/Dasra B, the most
recently reported CPC component that is important in kinetochore-microtubule attachment
error correction (19-21). The Aurora B kinase appears to be at least partially activated at the
onset of mitosis following association with INCENP and Survivin, after which further post-
translational modification events (including phosphorylation of two serines in the C-
terminus of INCENP) proceed and lead to full Aurora B activation (5-9). The remaining
three CPC components (INCENP, Survivin and Borealin) are thought to act as adaptor
proteins and direct the Aurora B kinase to specific substrates at various localizations during
different stages of cell mitosis. For example, Borealin has been shown to be the only CPC
component that demonstrates DNA binding and thus has been suggested to be responsible
for recruiting the CPC to the inner centromere during prometaphase through direct
interaction with centromeric DNA (22). Furthermore, a ternary CPC sub-complex
comprising Survivin and a short N-terminal fragment each from Borealin and INCENP
presents a composite molecular surface of conserved residues essential for central spindle
and midbody localization (23).
Within the CPC, the four proteins interact extensively. Figure 1 summarizes the domain
structures of the four CPC components and the mapping of their interaction regions. A
general feature of most chromosomal passenger proteins is low solubility and stability.
Borealin, an intrinsically unstructured protein, appears to be the least soluble CPC
component since full-length and N/C-terminal fragments of Borealin have all exhibited
high-order oligomerization characteristics (19, 22). Furthermore, our work has shown rapid
degradation of recombinant full-length Borealin expressed in E. coli. So far structural and
biophysical studies have only been reported for binary or ternary CPC sub-complexes
involving short Borealin fragments (23, 24), but it is not known whether these complexes
functionally behave in the same way as their corresponding native CPC sub-complexes
incorporating full-length Borealin.
In this study, we have developed an approach to circumvent the unfavorable solubility and
stability characteristics of full-length (f.l.) Borealin, and we produced sufficient amounts of
a binary CPC sub-complex comprising f.l. Borealin and Survivin (f.l. Survivin has been used
throughout this study) for protein-protein interaction studies using isothermal titration
calorimetry. In parallel, we performed identical ITC characterization of a binary CPC sub-
complex comprising an N-terminal fragment of Borealin (containing the entire Survivin-
recognition sequence, a region that Borealin also uses to interact with INCENP) and
Survivin. We observed striking differences in the protein-protein interaction behavior
between the Survivin-Borealin fragment complex and the corresponding complex
constituted by Survivin and f.l. Borealin. In addition, our study shows that the two Survivin-
Borealin complexes adopt different stoichiometries providing insight into their respective
three-dimensional (3D) structural assembly.
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MATERIALS AND METHODS
DNA Cloning and Protein Sample Preparation
The Borealin constructs (the full-length protein and the fragment comprising residues 13-92)
were each cloned into a pET21a vector derivative (Gev1, Addgene), which has a C-terminal
His6 tag and an N-terminal GB1 (immunoglobulin G binding domain B1 of streptococcal
protein G; 56 amino acid residues) tag. Survivin and INCENP1-69 were cloned into a
pET21a vector (MerckBiosciences) as a non-tagged and a C-terminal His6-tagged protein.
Proteins were expressed in E. coli strain DE3 T1R cells (Sigma-Aldrich) overnight at 18 °C
for GB1Borealinf.l. and GB1Borealin13-92 or at 25 °C for Survivin and INCENP1-69. The
Survivin-GB1Borealinf.l. and Survivin-GB1Borealin13-92 complexes were produced by co-
purification of the overnight induction cell cultures containing separately expressed Borealin
and non-tagged Survivin. The cell lysis buffer contains 50 mM Tris-HCl pH 8.0, 300 mM
NaCl, 0.5 mM TCEP and Roche protease inhibitors (Roche Applied Sciences). The cleared
cell lysate were purified using Ni-NTA affinity columns (MerckBiosciences) and the eluents
were subjected to extensive dialysis in buffer containing 50 mM Tris-HCl pH 8.0, 150 mM
NaCl, 1mM DTT. A final purification step was then carried out using size-exclusion
chromatography (SEC) on a Superdex 200 prep grade column (GE Healthcare). The protein
samples of His6-tagged INCENP1-69/Survivin/GB1 were purified using similar procedures.
Isothermal Titration Calorimetry (ITC)
ITC experiments were performed using a VP-ITC instrument (MicroCal Inc., USA).
Samples of the Survivin-GB1Borealinf.l. and Survivin-GB1Borealin13-92 complexes and
INCENP1-69 were dialyzed into buffer containing 50 mM Tris-HCl pH8.0, 150 mM NaCl, 1
mM DTT for 1 hour. Titrations were performed by injecting consecutive aliquots of
INCENP1-69 (63 μM) into the ITC cell (volume 1.5 ml) containing the
Survivin-GB1Borealinf.l. complex or the Survivin-GB1Borealin13-92 complex (both at 6.3
μM) at 10 °C. A repeat titration of INCENP1-69 (63 μM) into the Survivin-GB1Borealin13-92
complex (6.3 μM) was carried out at a different temperature of 20 °C in order to validate the
near zero enthalpy change observed at 10 °C. ITC data were corrected for heats of dilution
of the protein solution. Binding stoichiometry, enthalpy, entropy and binding constants were
determined by fitting the corrected data to a one site binding model. The ITC data were
fitted using Origin 7.0 (MicroCal Inc., USA). ITC experiments for the
Survivin-GB1Borealinf.l. complex were carried out immediately after the 1 hour dialysis
following the final step of purification using SEC. Each ITC experiment was completed
within one hour.
Similar ITC procedures were carried out for the titrations of GB1 (100 μM) into Survivin
(10 μM) at two temperatures (20 °C and 30 °C) in order to confirm that the GB1 tag used in
the Borealin constructs does not interact with Survivin.
Analytical UltraCentrifugation (AUC)
Sedimentation velocity experiments were performed using a Beckman Optima XL-I
analytical ultracentrifuge equipped with an interference optical system. The sample of the
Survivin-GB1Borealin13-92 complex was prepared with dilution buffer containing 50mM
Tris-HCl pH 8.0, 150mM NaCl, 0.5 mM TCEP and 1mM DTT. The aluminium double-
sector centrepieces were filled with 400 μl of the protein complex and 420 μl of the dilution
buffer, respectively. Samples were centrifuged at a speed of 40,000 rpm at 10°C using an
An50-Ti rotor. Scans were acquired at a wavelength of 280 nm at time intervals of 600
seconds. The partial specific volume of 0.72 ml/g for a 2:2 stoichiometry of the
Survivin-GB1Borealin13-92 complex was calculated based on amino acid composition (25).
Sedimentation velocity data were analysed using SEDFIT (26).
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Size-Exclusion Chromatography-Multi-Angle Laser Light Scattering (SEC-MALLS)
The molecular weight (M.W.) and M.W. distributions of the Survivin-GB1Borealin13-92
complex were determined by SEC conducted using a JASCO chromatography system
composed of dual PU1580 pumps, a UV1575 detector, a Dawn HELOS Laser photometer
and an Optilab rEX interferometric refractometer (Wyatt Technology, Santa Barbara, CA),
with a Superdex 200 10/300 GL analytical column (Pharmacia) at a flow rate of 0.5 ml/min
in buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.5 mM TCEP. Molecular
weight was analyzed using Astra (version 5.1.9.1) at a dn/dc value of 0.186 ml/g.
RESULTS
A Specific Protocol for the Preparation of a CPC Sub-Complex Comprising Full-Length
Borealin and Survivin
The challenges in producing good quality protein samples of CPC sub-complexes
incorporating f.l. Borealin include severe aggregation problems (most likely due to Borealin)
and Borealin degradation. In order to alleviate these problems with f.l. Borealin, we
introduced an N-terminal GB1 tag based on the highly soluble small immunoglobulin
binding domain B1 (56 residues) of streptococcal protein G, a tag that has the potential to
enhance the expression and solubility of target proteins (27). The addition of the GB1 tag to
Borealin significantly improved the protein yield in the soluble fractions compared to
Borealin constructs with no GB1 tag. In order to accurately assess whether GB1 interacts
with Survivin, we carried out ITC experiments where aliquots of purified protein samples of
GB1 (100μM) were titrated into 1.5 milliliters of purified Survivin sample (10 μM) at 20 °C
and 30 °C. No heat (enthalpy) change was detected under both experimental conditions
(Figure S1). These results are consistent with our initial observations that GB1 does not
interact with Survivin using protein pull-down assays and analytical SEC analysis of a
mixture of purified GB1 and Survivin where the two proteins elute separately (data not
shown). We then devised a specific protocol to produce tractable protein samples of a binary
CPC sub-complex comprising Survivin and f.l. Borealin (Survivin-GB1Borealinf.l.) for
protein-protein interaction studies using ITC. The protocol which includes protein
expression and purification using the nickel affinity column is described in the Materials and
Methods section. The eluents from the nickel column require extensive dialysis (at least 48
hours) in buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1mM DTT at 4 °C prior
to the final purification of the Survivin-GB1Borealinf.l. complex using SEC. In addition, the
Survivin-GB1Borealinf.l. complex is sensitive to high temperature (> 10 °C) and the
concentration process using bench-top centrifuges where there are at least two adverse
factors: the complex sticking to the concentrator membrane and the appreciable dissociation
of the complex at a relative centrifugation force (RCF) of 3112 ×g (4000 RPM on a Heraeus
Labofuge 400R bench top centrifuge with a swinging bucket rotor) as assessed using SEC
(data not shown). Therefore the concentration process needs to be avoided or carried out at a
lower RCF of 778 ×g.
ITC Reveals an Active Survivin-GB1Borealinf.l. Complex and an In-Active
Survivin-GB1Borealin13-92 Complex
Previous studies have shown clear biochemical evidence for in vitro complex formation
between Borealin and INCENP, and also between Survivin and INCENP, an interaction that
is enhanced by the presence of Borealin (19, 22). Since the Survivin-GB1Borealinf.l. complex
aggregates severely at a concentration above approximately 7 μM and shows signs of
degradation within 2 hours after the final SEC purification step, we chose to use ITC to
characterize the protein-protein interaction activity based on its speed and sensitivity. The
following ITC experiments were carried out within 2 hours of passing the
Survivin-GB1Borealinf.l. complex sample through the final SEC column. In the ITC
Zhou et al. Page 4
Biochemistry. Author manuscript; available in PMC 2009 September 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
experiments, 1.5 milliliters of the Survivin-GB1Borealinf.l. or the Survivin-GB1Borealin13-92
complex sample (both at 6.3 μM concentration) was titrated with aliquots of 63 μM purified
protein samples of an N-terminal fragment of INCENP (INCENP1-69, containing the entire
Borealin-Survivin recognition sequence). Strikingly, the ITC experiments suggest no
detectable interaction between the Survivin-GB1Borealin13-92 complex and INCENP1-69
based on no observed heat (enthalpy) change at two different temperatures (10 °C and 20
°C; Figure 2). This observation is consistent with our protein pull-down assay results where
non-tagged INCENP1-69 failed to bind to the His6-tagged Survivin-GB1 Borealin13-92
complex that was pre-bound to the nickel column (data not shown). On the other hand, the
Survivin-GB1Borealinf.l complex demonstrated a strong interaction with INCENP1-69 (27
nM affinity; Figure 2). These data suggest that Survivin-GB1Borealinf.l., rather than
Survivin-GB1Borealin13-92, is an active CPC sub-complex that is competent to interact
strongly with INCENP. The stoichiometry of the interaction between INCENP1-69 and the
Survivin-GB1Borealinf.l. complex is presumed to be 1:1 despite the fitted ITC data giving an
N value of ~0.75. The lower value of N is likely due to a finite level of degradation of
Borealin over the duration of the ITC experiment since our independent observations of
freshly purified protein samples of the Survivin-GB1Borealinf.l. complex show a small
percentage of degradation of Borealin within a 2 hour timescale (Figure S2).
Different Stoichiometries Are Adopted by the Survivin-GB1Borealin13-92 and
Survivin-GB1Borealinf.l. Complexes
Why do the two Survivin-Borealin complexes behave differently with respect to INCENP
binding? We characterized their respective solubility, stability and stoichiometry. The
complex of Survivin-GB1Borealin13-92 is highly soluble (up to 9 mg/ml without detectable
aggregation (assessed using SEC, data not shown) and stable (< 2 months at -80 °C).
Previous 3D structural studies show that Survivin is a homo-dimer in its isolated form and
adopts an elongated shape due to the presence of a protruding C-terminal ~65 Å-long α-
helix in each protomer (28-31). In our SEC analysis, purified protein samples of Survivin
(predicted M.W. 35.6 kDa as a homo-dimer including a 14-residue sequence derived from
the pET21a vector) elutes at a volume corresponding to a 58 kDa globular protein according
to M.W. calibrations using 29-700 kDa protein M.W. standards (Sigma-Aldrich; data not
shown). In order to accurately determine the M.W. and the stoichiometry of the
Survivin-GB1Borealin13-92 complex, we applied AUC and SEC-MALLS, two techniques
that allow estimation of the M.W. in a manner broadly independent of the hydrodynamic
anisotropy of the molecules under investigation. The AUC and SEC-MALLS analyses of the
Survivin-GB1Borealin13-92 complex suggested a M.W. of 73.9 ± 4.3 kDa and 80.9 ± 1.0
kDa, respectively (Figure 3). The data are consistent with a 2:2 stoichiometry between
Survivin (predicted M.W. 17.8 kDa) and GB1Borealin13-92 (predicted M.W. 19.9 kDa) in the
Survivin-GB1Borealin13-92 complex (predicted M.W. 75.4 kDa as a 2:2 complex).
In contrast, the Survivin-GB1Borealinf.l. complex has low solubility (severe aggregation at
above approximately 7 μM concentration) and low stability (degradation starts within 2
hours after the final SEC purification) therefore precluding M.W. characterizations using
AUC. We have attempted to use SEC-MALLS to determine the M.W. of the
Survivin-GB1Borealinf.l. complex at a concentration of 6.3 μM at 4 °C using freshly-made
samples. However, no reliable data could be obtained due to the low signal-to-noise level in
the elution profile detected by the refractive index detector (whose sensitivity is 10-100
times lower than that of a UV detector).
According to analytical SEC, the Survivin-GB1Borealin13-92 2:2 complex elutes at 12.92 ml,
whilst the Survivin-GB1Borealinf.l. complex elutes at a later volume of 13.27 ml (Figure 4).
The difference in the SEC retention volumes of the two Survivin-Borealin complexes
suggests that the M.W. of the Survivin-GB1Borealinf.l. complex is lower than that of the
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Survivin-GB1Borealin13-92 complex whose M.W. has been determined to be ~70-80 kDa
using AUC and SEC-MALLS. Based on the computed molecular masses of the expressed
polypeptides, the predicted M.W. of a Survivin-GB1Borealinf.l. heterodimer complex is 57.3
kDa. Therefore, the later retention volume of the Survivin-GB1Borealinf.l. complex
compared to that of the Survivin-GB1Borealin13-92 complex suggests that the former is most
likely to adopt a 1:1 stoichiometry in which f.l. Borealin is a monomer.
DISCUSSION
The observed differences in stability, solubility, stoichiometry and protein-protein
interaction activity between the two Survivin-Borealin complexes imply dramatic structural
differences. According to the recent crystal structure of a core Survivin-Borealin10-109-
INCENP1-58 1:1:1 complex, INCENP residues 1-47 and Borealin residues 15-62 form two
long helices that bind to the hydrophobic C-terminal helix of Survivin thus forming a 3-helix
bundle adjacent to the globular Survivin BIR domain ((23); Figure S3). Our data suggest
that the Survivin-GB1Borealin13-92 2:2 complex forms a structure in which the INCENP
binding surface is no longer presented, perhaps by forming a heterotetrameric 4-helix
bundle. Our Survivin-GB1Borealin13-92 2:2 complex, as well as other recently reported
Survivin-Borealin N-terminal fragment 2:2 complexes (23, 24), yielded only poorly
diffracting crystals possibly implying conformational heterogeneity. Despite the
observations that full-length Borealin as well as N- and C-terminal Borealin fragments form
high-order oligomers in vitro (19, 22), our analysis suggest that full-length Borealin is likely
to be a monomer when complexed with Survivin. Structurally the Survivin-GB1Borealinf.l.
complex is predicted to adopt a similar assembly to that within the ternary Survivin-
Borealin10-109-INCENP1-58 1:1:1 complex (23), in which the INCENP binding surface is
clearly exposed. Overall, our study emphasizes the importance of the presence of the C-
terminal region within f.l. Borealin for the composition of a fully active Survivin-Borealin
complex, possibly by providing steric hindrance to the formation of an otherwise stable
structure in which the INCENP recognition site is buried when a shorter Borealin fragment
is used. In addition, our study provides an example where a protein complex composed of
protein fragments that possess complete protein-protein interaction sequences demonstrates
different stoichiometry and protein-protein interaction behavior from the corresponding
protein complex of the full-length proteins.
So far, 3D structural studies of CPC sub-complexes involving full-length Survivin and
fragments of Aurora B, Borealin and INCENP have all demonstrated monomeric protein-
protein interactions (6, 23, 24). Our study provides evidence that full-length Borealin is
likely to interact with Survivin as a monomer despite previous observations that Borealin
and its N- and C-terminal fragments form high-order oligomers in vitro (19, 22). It is
plausible that the quaternary CPC adopts a 1:1:1:1 stoichiometry. However, there are still
extensive protein sequence regions in Borealin and INCENP (depicted as blank boxes in
Figure 1) that await characterization of their 3D structure and analysis of their involvement
in protein-protein interactions. In addition to the four reported CPC components, it cannot be
ruled out that new members of the CPC assembly might still come to light. Understanding
the structural geometry of the CPC represents an important step towards deciphering the
functional mechanism of the CPC during cell mitosis, a question that also requires
knowledge of the presently un-identified specific targets/substrates of the CPC at various
localizations of the mitotic cell.
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Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
CPC chromosomal passenger complex
f.l. full-length
ITC isothermal titration calorimetry
3D three-dimensional
GB1 immunoglobulin G binding domain B1 of streptococcal protein G
SEC size-exclusion chromatography
AUC analytical ultracentrifugation
SEC-MALLS size-exclusion chromatography-multi-angle laser light scattering
M.W. molecular weight
BIR baculovirus IAP (inhibitor of apoptosis proteins) repeat
Bor Borealin
Sur Survivin
RCF relative centrifugation force
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Figure 1.
A summary of observed protein-protein interactions (illustrated by two-way arrows) within
the CPC (1-4). Protein sequences of unknown structure and function are shown as blank
boxes. The molecular weights of the four CPC components are those from Homo sapiens.
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Figure 2.
Isothermal titration calorimetry. (A) Titration of the Survivin-GB1Borealinf.l. complex with
INCENP1-69 in buffer containing 50 mM Tris-HCl pH8.0, 150 mM NaCl, 1 mM DTT at 10
°C suggests strong binding interaction. (B) Titrations of the Survivin-GB1Borealin13-92
complex with INCENP1-69 at two temperatures of 10 °C (left) and 20 °C (right) in buffer
containing 50 mM Tris-HCl pH8.0, 150 mM NaCl, 1 mM DTT suggest near zero enthalpy
change implying no detectable interaction.
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Figure 3.
(A) Sedimentation velocity AUC analysis of the Survivin-GB1Borealin13-92 complex at three
concentrations (0.6, 0.96, 1.1 mg/ml) suggests a mean M.W. of 73.9 ± 4.3 kDa. (B) SEC-
MALLS analysis of the Survivin-GB1Borealin13-92 complex at 0.44 mg/ml suggests a M.W.
of 80.9 ± 1.0 kDa.
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Figure 4.
Analytical SEC reveals that the Survivin-GB1Borealinf.l. complex (magenta) elutes at a later
volume than the Survivin-GB1Borealin13-92 complex (green). The SDS-PAGEs show that
stable complexes are formed (the Survivin-GB1Borealin13-92 complex at 4.5 and 9.0 mg/ml,
and the Survivin-GB1Borealinf.l. complex at 0.18 mg/ml and 0.36 mg/ml or 6.3 μM) and can
be eluted by SEC.
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